The Impact of Human Herpesvirus 6B Reactivation on Early Complications following Allogeneic Hematopoietic Stem Cell Transplantation

This publication has 29 references indexed in Scilit:

• Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation
  Blood, 2006
• Infections with human herpesvirus 6 variant B delay platelet engraftment after allogeneic haematopoietic stem cell transplantation
  British Journal of Haematology, 2005
• Quantitative Detection and Differentiation of Human Herpesvirus 6 Subtypes in Bone Marrow Transplant Patients by Using a Single Real-Time Polymerase Chain Reaction Assay
  Transplantation and Cellular Therapy, 2005
• Clinical Outcomes of Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell Transplantation
  Clinical Infectious Diseases, 2005
• Human cytomegalovirus immediate-early mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic stem cell transplantation: a prospective, randomized, open-label trial
  Blood, 2003
• Real-Time PCR for Quantification of Human Herpesvirus 6 DNA from Lymph Nodes and Saliva
  Journal of Clinical Microbiology, 2002
• Human Herpesvirus 6 Reactivation and Encephalitis in Allogeneic Bone Marrow Transplant Recipients
  Clinical Infectious Diseases, 2001
• Impaired production of naive T lymphocytes in human T-cell leukemia virus type I–infected individuals: its implications in the immunodeficient state
  Blood, 2001
• High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients
  British Journal of Haematology, 2000
• Monitoring of human herpesviruses after allogeneic peripheral blood stem cell transplantation and bone marrow transplantation
  British Journal of Haematology, 1999